Financials in USD. Standardized financial statements.
A compact view of how SeaStar Medical Holding Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue? | $1.23M | $135,000 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +814.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $53,000 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $1.18M | $135,000 | $0 | $0 | $0 | $0 |
| Gross Margin? | +95.7% | +100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $13.36M | $17.98M | $14.21M | $11.61M | $4.45M | $6.45M |
| Operating Income? | -$12.18M | -$17.84M | -$14.21M | -$11.61M | -$4.45M | -$6.45M |
| EBITDA? | -$12.18M | -$24.58M | -$11.14M | -$11.56M | -$4.38M | $0 |
| Income Before Tax | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.60M | -$3.27M |
| Income Tax Expense | $3,000 | $3,000 | $0 | $1,000 | -$1,000 | $9,000 |
| Net Income? | -$12.15M | -$24.83M | -$26.23M | -$12.19M | -$4.60M | -$3.28M |
| EPS? | $-5.86 | $-66.30 | $-302.62 | $-233.80 | $-88.10 | $-0.10 |
| Diluted EPS? | $-5.86 | $-66.30 | $-302.62 | $-233.80 | $-88.10 | $-0.10 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality